Skip to content
JoelGalvan

JoelGalvan

View Video Stories
  • Home
  • Business
  • Culture
  • Sports
  • Home
  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.
  • Home
  • neutral

Tag: neutral

Goldman Sachs Begins coverage of GLOBALFOUNDRIES (GFS) Stock with a Neutral Rating
Posted in Business

Goldman Sachs Begins coverage of GLOBALFOUNDRIES (GFS) Stock with a Neutral Rating

Estimated read time 2 min read
Posted on July 13, 2025
by Joelgalvan

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is one of the Most Promising AI Stocks to Buy Now. Goldman Sachs began coverage of the company’s…

Learn More Leave a Comment on Goldman Sachs Begins coverage of GLOBALFOUNDRIES (GFS) Stock with a Neutral Rating
Motilal Oswal see 4% downside for Bharat Dynamics, starts coverage with neutral call amid lofty valuations
Posted in Business

Motilal Oswal see 4% downside for Bharat Dynamics, starts coverage with neutral call amid lofty valuations

Estimated read time 3 min read
Posted on July 10, 2025
by Joelgalvan

Motilal Oswal has initiated coverage on Bharat Dynamics Ltd with a ‘neutral’ rating and a target price of Rs 1,900,…

Learn More Leave a Comment on Motilal Oswal see 4% downside for Bharat Dynamics, starts coverage with neutral call amid lofty valuations
Citigroup Hikes JPMorgan Chase & Co. (JPM)’s Price Target To $275, Maintains Neutral Rating
Posted in Business

Citigroup Hikes JPMorgan Chase & Co. (JPM)’s Price Target To $275, Maintains Neutral Rating

Estimated read time 2 min read
Posted on July 2, 2025
by Joelgalvan

JPMorgan Chase & Co. (NYSE:JPM) is among the Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy. On June 26, Citigroup…

Learn More Leave a Comment on Citigroup Hikes JPMorgan Chase & Co. (JPM)’s Price Target To $275, Maintains Neutral Rating
Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
Posted in Business

Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June

Estimated read time 2 min read
Posted on June 25, 2025
by Joelgalvan

Barclays lowered its price target on Bausch & Lomb (NYSE: BLCO) from $19 to $16 on June 6, maintaining an…

Learn More Leave a Comment on Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
Market movement to be limited in coming quarter; be neutral on pharma: Amit Khurana
Posted in Business

Market movement to be limited in coming quarter; be neutral on pharma: Amit Khurana

Estimated read time 4 min read
Posted on June 23, 2025
by Joelgalvan

Amit Khurana, Head of Institutional Equities, Dolat Capital, says market movement is expected to be limited in the coming quarter.…

Learn More Leave a Comment on Market movement to be limited in coming quarter; be neutral on pharma: Amit Khurana
JPMorgan Lowers PT for Occidental Petroleum (OXY), Keeps Neutral Rating
Posted in Business

JPMorgan Lowers PT for Occidental Petroleum (OXY), Keeps Neutral Rating

Estimated read time 2 min read
Posted on June 22, 2025
by Joelgalvan

Occidental Petroleum Corporation (NYSE:OXY) is one of the 10 Best Oil and Gas Stocks to Buy Now. On May 9,…

Learn More Leave a Comment on JPMorgan Lowers PT for Occidental Petroleum (OXY), Keeps Neutral Rating
Motilal Oswal downgrades BSE to ‘Neutral’, cuts target price to Rs 2,300 on expiry shift impact
Posted in Business

Motilal Oswal downgrades BSE to ‘Neutral’, cuts target price to Rs 2,300 on expiry shift impact

Estimated read time 3 min read
Posted on June 18, 2025
by Joelgalvan

Citing concerns over a potential market share loss following the shift in weekly contract expiries, domestic brokerage firm Motilal Oswal…

Learn More Leave a Comment on Motilal Oswal downgrades BSE to ‘Neutral’, cuts target price to Rs 2,300 on expiry shift impact
UBS Remains Neutral on Brown-Forman Corporation (BF-B), Trims PT to $30
Posted in Business

UBS Remains Neutral on Brown-Forman Corporation (BF-B), Trims PT to $30

Estimated read time 2 min read
Posted on June 12, 2025
by Joelgalvan

Brown-Forman Corporation (NYSE:BF-B) is one of the best wide moat stocks to buy now. On June 9, UBS analyst Peter…

Learn More Leave a Comment on UBS Remains Neutral on Brown-Forman Corporation (BF-B), Trims PT to $30
Redburn-Atlantic Upgrades Charles Schwab (SCHW) to Neutral, Raises PT to $82
Posted in Business

Redburn-Atlantic Upgrades Charles Schwab (SCHW) to Neutral, Raises PT to $82

Estimated read time 2 min read
Posted on June 11, 2025
by Joelgalvan

The Charles Schwab Corporation (NYSE:SCHW) is one of the best wide moat stocks to buy now. On June 9, Redburn-Atlantic…

Learn More Leave a Comment on Redburn-Atlantic Upgrades Charles Schwab (SCHW) to Neutral, Raises PT to $82
BTIG Downgrades Globus Medical (GMED) to Neutral on Spine Business Concerns
Posted in Business

BTIG Downgrades Globus Medical (GMED) to Neutral on Spine Business Concerns

Estimated read time 2 min read
Posted on May 29, 2025
by Joelgalvan

On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns about…

Learn More Leave a Comment on BTIG Downgrades Globus Medical (GMED) to Neutral on Spine Business Concerns

Posts navigation

← Older Articles

Recent Posts

  • Sharks face fight to keep star on the hook, Bronco rejects Manly offer to re-sign
  • Microsoft Corporation (MSFT) Soared as Azure Revenue Grew 35%
  • Brian Daboll Reveals Big Injury Update On Malik Nabers
  • Recognition Music Group plans $372m bond sale – as value of catalog once known as Hipgnosis Songs Fund continues to balloon
  • Ohtani homers in fifth consecutive game, tying a Dodgers franchise record

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.